Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment

Pancreatic ductal adenocarcinoma (PDAC) is one of the top five deadliest forms of cancer with very few treatment options. The 5-year survival rate for PDAC is 10% following diagnosis. Cadherin 11 (Cdh11), a cell-to-cell adhesion molecule, has been suggested to promote tumor growth and immunosuppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebastian, Aimy, Martin, Kelly A., Peran, Ivana, Hum, Nicholas R., Leon, Nicole F., Amiri, Beheshta, Wilson, Stephen P., Coleman, Matthew A., Wheeler, Elizabeth K., Byers, Stephen W., Loots, Gabriela G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639148/
https://www.ncbi.nlm.nih.gov/pubmed/37954069
http://dx.doi.org/10.3389/fonc.2023.1286861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639148/
https://www.ncbi.nlm.nih.gov/pubmed/37954069
http://dx.doi.org/10.3389/fonc.2023.1286861

Ejemplares similares